Heterogeneous Hippo pathway (YAP/TAZ) activation in lung adenocarcinoma drives tumor progression by enabling ferroptosis resistance via non-cell-autonomous mechanisms. This evidence concerns the gene YAP1 and lung adenocarcinoma.